BNN
370.8K

Elodie Zone Defends Martina Amid GLP-1 Debate

27 September 2026 · 17
Elodie Zone Defends Martina Amid GLP-1 Debate

Elodie Zone has publicly defended fellow Kenyan influencer Martina amidst the ongoing controversy surrounding GLP-1 medications. This debate has sparked significant discussion on social media, particularly regarding the appropriateness of these medications for individuals without Type 2 diabetes.

In her defense, Elodie emphasized that GLP-1 medications are specifically intended for those diagnosed with Type 2 diabetes and should not be misused by others. She urged the public to redirect their criticism away from Martina and instead focus on issues that can genuinely contribute to the welfare of the country.

Elodie Zone is a prominent figure in the Kenyan entertainment scene, known for her vibrant personality and active presence on social media. She has garnered a following for her candid discussions on various topics, including health and wellness, which makes her stance on this issue particularly impactful.

The broader context of this situation involves a growing trend among influencers discussing weight loss and health solutions, which has led to debates about the ethical implications of promoting certain medications. Recently, other public figures, including Kalekye Mumo, have shared their experiences with GLP-1 drugs, further fueling this conversation. As the public discourse evolves, it raises questions about responsibility and the influence of social media personalities on health-related choices.

#elodiezone

Comments
← More on BNN